Event-Driven Stocks

Fortress Biotech, Inc.

FBIONasdaq

Healthcare · Pharmaceutical Preparations · DE · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs● 1 good● 4 warning● 1 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$61.2M$55.1M$59.7M$71.0M$63.1M$44.5M
Operating income−$70.2M−$110.4M−$142.3M−$203.6M−$188.5M−$94.3M
Net income$6.8M−$46.0M−$60.6M−$86.6M−$64.7M−$46.5M
Total assets$185.5M$144.2M$167.5M$294.3M$396.5M$333.4M
Total liabilities$123.4M$145.9M$165.9M$244.3M$170.6M$136.4M
Equity$49.9M$22.7M$22.5M$41.7M$108.7M$100.3M
EPS (diluted)$-0.07$-2.69$-8.47$-15.97$-0.79—
Shares out.31.4M27.9M15.1M7.4M101.4M78.5M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
−114.7%
Net margin
11.1%
Return on equity
13.7%
Return on assets
3.7%
Return on capital (ROCE)
−51.7%
Liabilities / assets
66.5%
Debt / equity
2.47×
Book value / share
$1.59
Revenue growth (YoY)
11.1%
Net income growth (YoY)
—

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-12.40distress
Accruals / assets
39.1%high accruals
Beneish M-Score
1.07elevated
Piotroski F-Score
5/9mixed

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
55
/ 100
Profitability 60Growth 100Catalyst 67Earnings quality 0Financial strength 50

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →

Signs

● 1 severe● 4 warning● 1 good
  • Altman Z″ in the distress zone
  • Operating losses (negative operating margin)
  • Negative operating cash flow
  • High accruals — earnings-quality risk
  • Beneish M-Score elevated — earnings-manipulation screen flag
  • Revenue is growing year-over-year

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
May 15, 20264.9M14.5+5.0%
Apr 30, 20264.6M17.8+2.3%
Apr 15, 20264.5M8.4+4.2%
Mar 31, 20264.4M9.2+2.0%
Mar 13, 20264.3M9.6-4.6%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (4)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.